Fn. Ko et al., MECHANISM OF ACTION OF P-CHLOROBIPHENYL ON THE INHIBITION OF PLATELET-AGGREGATION, Journal of Pharmacy and Pharmacology, 48(4), 1996, pp. 395-400
p-Chlorobiphenyl (1-50 mu M) concentration-dependently inhibited the a
ggregation and release reaction of rabbit washed platelets induced by
arachidonic acid and collagen, but not those induced by platelet-activ
ating factor (PAF), U46619 and thrombin. The IC50 values of p-chlorobi
phenyl on the arachidonic acid and collagen-induced platelet aggregati
on were 2.9 +/- 0.5 and 12.8 +/- 2.3 mu M, respectively. The formation
of both platelet thromboxane B-2 and prostaglandin D-2 caused by arac
hidonic acid was inhibited by p-chlorobiphenyl concentration-dependent
ly. In myo-[H-3]inositol-labeled and fura-2-loaded platelets, [H-3]ino
sitol monophosphate generation and the rise in intracellular Ca2+ stim
ulated by arachidonic acid were inhibited by p-chlorobiphenyl. In huma
n platelet-rich plasma, p-chlorobiphenyl and indomethacin prevented th
e secondary aggregation and blocked ATP release from platelets induced
by adenosine 5'-diphosphate and adrenaline without affecting the prim
ary aggregation. It is concluded that p-chlorobiphenyl may be a cyclo-
oxygenase inhibitor and its antiplatelet action is mainly due to the i
nhibition of thromboxane formation.